BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6186269)

  • 21. [Prognostic value of pregnancy-specific serum beta glycoprotein in threatened abortion].
    Karg N; Csaba I; Than G; Vereczkey G; Sárdi J; Szabó D
    Orv Hetil; 1980 Apr; 121(16):939-41. PubMed ID: 6155653
    [No Abstract]   [Full Text] [Related]  

  • 22. [HCG and SP-1 in normal pregnancy and in high-risk early pregnancy].
    Vetter K; Flury G; Keller PJ
    Geburtshilfe Frauenheilkd; 1982 Dec; 42(12):868-70. PubMed ID: 6984404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Fluctuations in pregnancy-associated protein A (PAPP-A) levels in the sera of pregnant women].
    Imaizumi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Feb; 35(2):159-67. PubMed ID: 6190967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy-specific beta 1-glycoprotein as a prognostic indicator in complications of early pregnancy.
    Ho PC; Jones WR
    Am J Obstet Gynecol; 1980 Oct; 138(3):253-6. PubMed ID: 6968160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The concentrations of SP1 beta and SP1 alpha in retroplacental and peripheral blood at term.
    Ahmed AG; Klopper A
    Eur J Obstet Gynecol Reprod Biol; 1983 Oct; 16(2):77-81. PubMed ID: 6196240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pregnancy-associated plasma protein-A (PAPP-A) and hCG in early pregnancy.
    Bischof P; DuBerg S; Herrmann W; Sizonenko PC
    Br J Obstet Gynaecol; 1981 Oct; 88(10):973-5. PubMed ID: 6169364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human chorionic gonadotrophin and pregnancy-specific beta-1-glycoprotein in predicting pregnancy outcome and in association with early pregnancy vomiting.
    Kauppila A; Heikinheimo M; Lohela H; Ylikorkala O
    Gynecol Obstet Invest; 1984; 18(1):49-53. PubMed ID: 6611286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Threatened miscarriage and intrauterine hematomas. Sonographic and biochemical studies.
    Stabile I; Campbell S; Grudzinskas JG
    J Ultrasound Med; 1989 Jun; 8(6):289-92. PubMed ID: 2472492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of the new placental proteins in trophoblastic disease.
    Tsakok FH; Koh S; Chua SE; Ratnam SS; Teisner B; Jones GR; Sinosich M; Grudzinskas JG
    Br J Obstet Gynaecol; 1983 May; 90(5):483-6. PubMed ID: 6189512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimation of gestational age by last menstrual period, by ultrasound scan and by SP1 concentration: comparisons with date of delivery.
    Ahmed AG; Klopper A
    Br J Obstet Gynaecol; 1986 Feb; 93(2):122-7. PubMed ID: 3511954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The disappearance rate of Schwangerschaftsprotein 1 in normal and pathological pregnancies.
    Huttenmoser JL; Weil-Franck C; Bischof P
    Br J Obstet Gynaecol; 1987 May; 94(5):420-4. PubMed ID: 3495291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal serum pregnancy-associated plasma protein A (PAPP-A) but not pregnancy-specific beta1-glycoprotein (SP1) is a useful second-trimester marker for fetal trisomy 18.
    Bersinger NA; Leporrier N; Herrou M; Leymarie P
    Prenat Diagn; 1999 Jun; 19(6):537-41. PubMed ID: 10416969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and significance of subchorionic hemorrhage in threatened abortion: a sonographic study.
    Pedersen JF; Mantoni M
    AJR Am J Roentgenol; 1990 Mar; 154(3):535-7. PubMed ID: 2106217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The diagnostic value of maternal pregnancy-specific beta 1-glycoprotein in threatened abortion.
    Karg NJ; Csaba IF; Than GN; Vereczkey G; Szalmásy M
    Z Geburtshilfe Perinatol; 1981 Feb; 185(1):38-40. PubMed ID: 6972125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of SP1 beta-1-glycoprotein in threatened abortion].
    Iannotti G; Paladini A; Iannantuoni NM; Campanile M
    Minerva Ginecol; 1980 Dec; 32(12):1115-9. PubMed ID: 6974834
    [No Abstract]   [Full Text] [Related]  

  • 36. Radioimmunoassay of SP1 (pregnancy-specific beta1-glycoprotein) in maternal blood and in amniotic fluid normal and pathologic pregnancies.
    Würz H; Geiger W; Künzig HJ; Jabs-Lehmann A; Bohn H; Lüben G
    J Perinat Med; 1981; 9(2):67-78. PubMed ID: 6787188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the concentration of schwangerschaftsprotein 1 (SP1) in the serum and urine of pregnant women.
    Bersinger N; Luke G; Klopper A
    Gynecol Obstet Invest; 1986; 21(3):113-6. PubMed ID: 3486804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical significance of pregnancy-specific beta 1-glycoprotein analysis in endocrine tests of the gonadal and placental system].
    Mochizuki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():1274-8. PubMed ID: 2560074
    [No Abstract]   [Full Text] [Related]  

  • 39. The development and validation of a radioimmunoassay for human pregnancy-associated plasma protein A (PAPP-A).
    Pinto Furtado LG; Bolton AE; Grudzinskas JG; Chapman MG; Sinosich MJ; Sharma V
    Arch Gynecol; 1984; 236(2):83-91. PubMed ID: 6084475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The demonstration of two pregnancy-associated proteins with SP1 determinants in placental extracts.
    Ahmed AM; Toop KM; Klopper A
    Placenta; 1981; 2(1):45-51. PubMed ID: 6163149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.